{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:20:24Z","timestamp":1778811624314,"version":"3.51.4"},"reference-count":21,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["Indian J Dermatol Venereol Leprol"],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Mucous membrane pemphigoid (MMP) is a rare subepidermal autoimmune blistering disorder. The clinical and demographic parameters of this disease in Indian patients have not yet been elucidated in detail.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>We aimed to study the clinical and demographic characteristics, disease course, and treatment aspects of MMP patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The data for this study were obtained by reviewing the case record forms of patients registered in the Autoimmune Bullous Disease (AIBD) Clinic of the Department of Dermatology, Venereology &amp; Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, a tertiary care centre in India. The diagnosis of MMP was established on the basis of clinical and immune-histopathological features which are consistent with standard diagnostic criteria for the disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 52 patients with MMP registered in the AIBD clinic were included. The mean age at disease onset was 50 years and the average age at presentation was 56 years. Females outnumbered males in the study with a ratio of 1.36:1.<\/jats:p>\n<jats:p>The oral and ocular mucosae were the most commonly affected sites (82.6% and 63.4% respectively). Visual difficulty was reported by half the patients (26 of 52 patients).<\/jats:p>\n<jats:p>IgG, C3, and IgA deposits were detected on direct immunofluorescence (DIF) in 29, 21, and 11 patients, respectively. Serologic analysis was performed in only 7 of the patients and of these, just 1 exhibited a positive result on multivariant ELISA and epidermal pattern of binding on salt split skin indirect immunofluorescence.<\/jats:p>\n<jats:p>Most patients were treated with prednisolone (44 of 52). Steroid-sparing adjuvants were used in combination including cyclophosphamide, azathioprine, methotrexate, dapsone, and colchicine. Rituximab was administered in 7 patients with severe or refractory disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Limitations<\/jats:title>\n<jats:p>This is a retrospective analysis of data available from a clinic registry. In patients with negative direct immunofluorescence on biopsy, the diagnosis was based on clinico-pathologic consensus.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>MMP is not as uncommon in India as the paucity of reports suggest. Visual complications are frequent in Indian MMP patients. A high index of suspicion is required for early diagnosis and appropriate treatment to prevent ocular complications.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/ijdvl_273_2023","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T05:53:57Z","timestamp":1720245237000},"page":"763-768","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical and demographic characteristics of mucous membrane pemphigoid in India: A retrospective analysis"],"prefix":"10.25259","volume":"90","author":[{"given":"Dipankar","family":"De","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Hanumanthu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitender","family":"Jinagal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Handa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debajyoti","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biman","family":"Saikia","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma","family":"Nahar Saikia","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bishan","family":"Dass Radotra","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjana Walker","family":"Minz","sequence":"additional","affiliation":[{"name":"Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2024,7,6]]},"reference":[{"key":"10.25259\/IJDVL_273_2023\/ref-1","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/jdv.17397","article-title":"European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I","volume":"35","author":"Rashid","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.25259\/IJDVL_273_2023\/ref-2","doi-asserted-by":"publisher","first-page":"103036","DOI":"10.1016\/j.autrev.2022.103036","article-title":"Mucous membrane pemphigoid","volume":"21","author":"Du","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.25259\/IJDVL_273_2023\/ref-3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.oooo.2015.01.024","article-title":"World workshop on oral medicine VI: A systematic review of the treatment of mucous membrane pemphigoid","volume":"120","author":"Taylor","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.25259\/IJDVL_273_2023\/ref-4","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3389\/fimmu.2019.02219","article-title":"A retrospective study of patient-reported data of bullous pemphigoid and mucous membrane pemphigoid from a US-based registry","volume":"10","author":"Lee","year":"2019","journal-title":"Front immunol"},{"key":"10.25259\/IJDVL_273_2023\/ref-5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/ced.13996","article-title":"Mucous membrane pemphigoid and oral blistering diseases","volume":"44","author":"Carey","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.25259\/IJDVL_273_2023\/ref-6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12026-019-09087-7","article-title":"Ocular mucous membrane pemphigoid: A review","volume":"67","author":"Taurone","year":"2019","journal-title":"Immunol Res"},{"key":"10.25259\/IJDVL_273_2023\/ref-7","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.1111\/ijd.13339","article-title":"Clinical and immunological study of mucous membrane pemphigoid in a cohort of Indian patients","volume":"55","author":"Kanwar","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.25259\/IJDVL_273_2023\/ref-8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4103\/0378-6323.175928","article-title":"Clinical, demographic and immunopathological spectrum of subepidermal autoimmune bullous diseases at a tertiary center: A 1-year audit","volume":"82","author":"De","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.25259\/IJDVL_273_2023\/ref-9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ajo.2017.08.009","article-title":"Clinical implications of direct immunofluorescence findings in patients with ocular mucous membrane pemphigoid","volume":"183","author":"Labowsky","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.25259\/IJDVL_273_2023\/ref-10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/s1542-0124(12)70281-1","article-title":"Ocular mucous membrane pemphigoid: Diagnosis and management strategies","volume":"6","author":"Saw","year":"2008","journal-title":"Ocul Surf"},{"key":"10.25259\/IJDVL_273_2023\/ref-11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jaad.2014.08.024","article-title":"Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts","volume":"72","author":"Murrell","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/IJDVL_273_2023\/ref-12","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/jamadermatol.2021.1036","article-title":"Assessment of diagnostic strategy for mucous membrane pemphigoid","volume":"157","author":"Rashid","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.25259\/IJDVL_273_2023\/ref-13","article-title":"Ocular pemphigoid","volume-title":"StatPearls","author":"Schonberg","year":"2023"},{"key":"10.25259\/IJDVL_273_2023\/ref-14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/ICU.0000000000000441","article-title":"Cataract surgery in ocular surface diseases: Clinical challenges and outcomes","volume":"29","author":"Sangwan","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"10.25259\/IJDVL_273_2023\/ref-15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaad.2021.11.061","article-title":"Insights into clinical and diagnostic findings as well as treatment responses in patients with mucous membrane pemphigoid: A retrospective cohort study","volume":"87","author":"Rashid","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/IJDVL_273_2023\/ref-16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fmed.2018.00020","article-title":"Direct immunofluorescence using non-lesional buccal mucosa in mucous membrane pemphigoid","volume":"5","author":"Kamaguchi","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.25259\/IJDVL_273_2023\/ref-17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jds.2021.11.007","article-title":"Oral mucous membrane pemphigoid in a group of Thai patients-A 15-year retrospective study","volume":"17","author":"Buajeeb","year":"2022","journal-title":"J Dent Sci"},{"key":"10.25259\/IJDVL_273_2023\/ref-18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jaad.2017.05.056","article-title":"Desquamative gingivitis: Clinical findings and diseases","volume":"78","author":"Maderal","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/IJDVL_273_2023\/ref-19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jaad.2017.04.1140","article-title":"Desquamative gingivitis: Diagnosis and treatment","volume":"78","author":"Maderal","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/IJDVL_273_2023\/ref-20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/odi.13083","article-title":"World Workshop of Oral Medicine VII: A systematic review of immunobiologic therapy for oral manifestations of pemphigoid and pemphigus","volume":"25","author":"Mays","year":"2019","journal-title":"Oral Dis"},{"key":"10.25259\/IJDVL_273_2023\/ref-21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1365-2230.2009.03222.x","article-title":"Coexistence of mucous membrane pemphigoid and connective-tissue disease","volume":"35","author":"Malik","year":"2010","journal-title":"Clin Exp Dermatol"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/clinical-and-demographic-characteristics-of-mucous-membrane-pemphigoid-in-india-a-retrospective-analysis\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/clinical-and-demographic-characteristics-of-mucous-membrane-pemphigoid-in-india-a-retrospective-analysis\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T06:24:51Z","timestamp":1731479091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/clinical-and-demographic-characteristics-of-mucous-membrane-pemphigoid-in-india-a-retrospective-analysis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":21,"alternative-id":["10.25259\/IJDVL_273_2023"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_273_2023","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,6]]},"article-number":"763"}}